PD-L1 expression in malignant pleural effusion samples and its correlation with oncogene mutations in non-small cell lung cancer

BACKGROUND: Programmed death ligand 1 (PD-L1) tumor proportion score (TPS) is currently widely used for selection of immune therapies in non-small cell lung cancer (NSCLC). Most of samples for PD-L1 expression were obtained from tumor tissue. However, the feasible of malignant pleural effusion (MPE)...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Zhengbo, Cheng, Guoping, Zhang, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212145/
https://www.ncbi.nlm.nih.gov/pubmed/32395276
http://dx.doi.org/10.21037/jtd.2020.02.06

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212145/
https://www.ncbi.nlm.nih.gov/pubmed/32395276
http://dx.doi.org/10.21037/jtd.2020.02.06

Ejemplares similares